Suppr超能文献

P2X(7) 受体与巨噬细胞功能。

P2X(7) receptor and macrophage function.

机构信息

Davis Heart and Lung Research Institute, Division of Pulmonary, Allergy, Critical Care and Sleep Medicine, The Ohio State University, Columbus, OH, USA,

出版信息

Purinergic Signal. 2009 Jun;5(2):189-95. doi: 10.1007/s11302-009-9131-9. Epub 2009 Feb 13.

Abstract

Macrophages are unique innate immune cells that play an integral role in the defense of the host by virtue of their ability to recognize, engulf, and kill pathogens while sending out danger signals via cytokines to recruit and activate inflammatory cells. It is becoming increasingly clear that purinergic signaling events are essential components of the macrophage response to pathogen challenges and disorders such as sepsis may be, at least in part, regulated by these important sensors. The activation of the P2X(7) receptor is a powerful event in the regulation of the caspase-1 inflammasome. We provide evidence that the inflammasome activation requires "priming" of macrophages prior to ATP activation of the P2X(7)R. Inhibition of the inflammasome activation by the tyrosine kinase inhibitor, AG126, suggests regulation by phosphorylation. Finally, the P2X(7)R may also be activated by other elements of the host response such as the antimicrobial peptide LL-37, which adds a new, physiologically relevant agonist to the P2X(7)R pathway. Therapeutic approaches to inflammation and sepsis will certainly be enhanced by an increased understanding of how purinergic receptors modulate the inflammasomes.

摘要

巨噬细胞是独特的先天免疫细胞,由于其能够识别、吞噬和杀死病原体的能力,同时通过细胞因子发出危险信号招募和激活炎症细胞,因此在宿主防御中发挥着重要作用。越来越明显的是,嘌呤能信号事件是巨噬细胞对病原体挑战反应的重要组成部分,败血症等疾病可能至少部分受到这些重要传感器的调节。P2X(7)受体的激活是调控半胱天冬酶-1 炎性小体的一个有力事件。我们提供的证据表明,炎性小体的激活需要在 ATP 激活 P2X(7)R 之前对巨噬细胞进行“预激活”。酪氨酸激酶抑制剂 AG126 抑制炎性小体的激活表明其受到磷酸化调节。最后,P2X(7)R 也可能被宿主反应的其他因素激活,如抗菌肽 LL-37,这为 P2X(7)R 途径增加了一种新的、生理相关的激动剂。对嘌呤能受体如何调节炎性小体的理解的增加,必将增强对炎症和败血症的治疗方法。

相似文献

1
P2X(7) receptor and macrophage function.P2X(7) 受体与巨噬细胞功能。
Purinergic Signal. 2009 Jun;5(2):189-95. doi: 10.1007/s11302-009-9131-9. Epub 2009 Feb 13.
2
Purinergic receptor P2X₇: a novel target for anti-inflammatory therapy.嘌呤能受体P2X₇:抗炎治疗的新靶点。
Bioorg Med Chem. 2014 Jan 1;22(1):54-88. doi: 10.1016/j.bmc.2013.10.054. Epub 2013 Nov 11.
8
P2X ion channel receptors and inflammation.P2X离子通道受体与炎症
Purinergic Signal. 2016 Mar;12(1):59-67. doi: 10.1007/s11302-015-9493-0. Epub 2016 Jan 6.
10
The P2X(7) receptor and intracellular pathogens: a continuing struggle.P2X(7) 受体与细胞内病原体:持续的斗争。
Purinergic Signal. 2009 Jun;5(2):197-204. doi: 10.1007/s11302-009-9130-x. Epub 2009 Feb 12.

引用本文的文献

本文引用的文献

1
Inhibition of the human P2X7 receptor by a novel protein tyrosine kinase antagonist.
Biochem Biophys Res Commun. 2008 Jan 18;365(3):515-20. doi: 10.1016/j.bbrc.2007.11.008. Epub 2007 Nov 20.
9
Mechanisms of caspase-1 activation by P2X7 receptor-mediated K+ release.P2X7受体介导的钾离子释放激活半胱天冬酶-1的机制。
Am J Physiol Cell Physiol. 2004 May;286(5):C1100-8. doi: 10.1152/ajpcell.00494.2003. Epub 2003 Dec 24.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验